Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Taiwan Semiconductor, Maintains $110 Price Target By Benzinga Newsdesk Today, 9:55 AM Needham analyst Charles Shi reiterates Taiwan Semiconductor (NYSE:TSM) with a Buy and maintains $110 price target. TSM
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on HashiCorp, Maintains $39 Price Target By Benzinga Newsdesk Today, 9:55 AM Needham analyst Alex Henderson reiterates HashiCorp (NASDAQ:HCP) with a Buy and maintains $39 price target. HCP
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Stratasys, Maintains $15 Price Target By Benzinga Newsdesk Today, 9:55 AM Needham analyst James Ricchiuti reiterates Stratasys (NASDAQ:SSYS) with a Buy and maintains $15 price target. SSYS
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on AgileThought, Maintains $7 Price Target By Benzinga Newsdesk Today, 9:55 AM Needham analyst Mayank Tandon reiterates AgileThought (NASDAQ:AGIL) with a Buy and maintains $7 price target. AGIL
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Neutral on Akebia Therapeutics, Maintains $1.25 Price Target By Benzinga Newsdesk Today, 9:55 AM HC Wainwright & Co. analyst Ed Arce reiterates Akebia Therapeutics (NASDAQ:AKBA) with a Neutral and maintains $1.25 price target. AKBA
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on aTyr Pharma, Maintains $35 Price Target By Benzinga Newsdesk Today, 9:55 AM HC Wainwright & Co. analyst Joseph Pantginis reiterates aTyr Pharma (NASDAQ:LIFE) with a Buy and maintains $35 price target. LIFE
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Aldeyra Therapeutics, Maintains $15 Price Target By Benzinga Newsdesk Today, 9:55 AM HC Wainwright & Co. analyst Matthew Caufield reiterates Aldeyra Therapeutics (NASDAQ:ALDX) with a Buy and maintains $15 price target. ALDX
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Compass Pathways, Maintains $120 Price Target By Benzinga Newsdesk Today, 9:55 AM HC Wainwright & Co. analyst Patrick Trucchio reiterates Compass Pathways (NASDAQ:CMPS) with a Buy and maintains $120 price target. CMPS
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $10 Price Target By Benzinga Newsdesk Today, 9:55 AM HC Wainwright & Co. analyst Patrick Trucchio reiterates Cybin (AMEX:CYBN) with a Buy and maintains $10 price target. CYBN
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Coursera, Maintains $19 Price Target By Benzinga Newsdesk Today, 9:55 AM Needham analyst Ryan MacDonald reiterates Coursera (NYSE:COUR) with a Buy and maintains $19 price target. COUR